Age-related uterine changes and its association with poor reproductive outcomes: a systematic review and meta-analysis

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Marti-Garcia, Diana
  • Martinez-Martinez, Asunta
  • Sanz, Francisco Jose
  • del Aguila, Nataly

Grupos

Abstract

Background The decline in women's fertility becomes clinically relevant between 35-40 years old, when there is insufficient ovarian activity, and it becomes more difficult to achieve pregnancy naturally and through artificial reproductive technologies. A competent endometrium is required for establishing and maintaining a pregnancy to term, however, experts in the field underestimate the contribution of endometrial age and its impact on reproductive outcomes remains unclear. Study design A systematic search of full-text articles available in PubMed was conducted to retrieve relevant studies published until March 2023. Search terms included: endometrium, uterus, age, aging, pregnancy, and oocyte donation. Terms related to reproductive pathologies were excluded. Eligibility criteria included original, rigorous, and accessible peer-reviewed work, published in English on the effect of age on the uterus and endometrium. Results From 11,354 records identified, 142 studies were included for systematic review, and 59 were eligible for meta-analysis of endometrial thickness (n = 7), pregnancy rate (n = 22), implantation rate (n = 10), live birth rate (n = 10) and pregnancy loss rate (n = 11). Studies for the meta-analysis of reproductive outcomes only included transfers of embryos from ovum donation (ovum donors < 36 years old). Age shrinks the uterus; depletes endometrial blood supply through narrow uterine veins and a progressive loss of uterine spiral arteries; disrupts endometrial architecture and cellular composition; alters hormone production, shortening menstrual cycle length and impeding endometrial progression to the secretory stage; and dysregulates key endometrial functions such as adhesion, proliferation, apoptosis, and receptivity, among others. Women over 35-40 years old had significantly thinner endometrium (MD 0.52 mm). Advanced maternal age is associated with lower odds of achieving implantation (27%) and clinical pregnancy (20%), or higher odds of experiencing pregnancy loss (44%). Conclusion Due to the effect of age on endometrium reported in this review, managing patients with advanced maternal age may require considering the endometrial factor as a potential tissue to treat with anti-aging strategies. This review provides researchers and clinicians with an updated and in-depth summary of this topic, encouraging the development of new tailored anti-aging and preventive strategies for precision medicine in endometrial factor in infertility.

Datos de la publicación

ISSN/ISSNe:
1477-7827, 1477-7827

REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY  BIOMED CENTRAL LTD

Tipo:
Review
Páginas:
-
Factor de Impacto:
1,198 SCImago
Cuartil:
Q1 SCImago

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Uterus; Endometrium; Reproductive outcomes; Pregnancy; Implantation; Endometrial thickness; Uterine morphology; Uterine vasculature; Endometrial histology; Women's age

Proyectos asociados

ESTUDIO DE LA ENFERMEDAD METASTASICA EN EL TEJIDO OVARICO CRIOPRESERVADO DE MUJERES CON CANCER DE MAMA

Investigador Principal: ANTONIO PELLICER MARTÍNEZ

PI08/90483 . INSTITUTO DE SALUD CARLOS III . 2009

CONTRATO POSTDOCTORAL DE INVESTIGACION SARA BORRELL

CD11/00292 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2012

CONTRATO POSTDOCTORAL DE INVESTIGACION SARA BORELL

CD12/00568 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2013

CONTRATO POST FSE (RIO HORTEGA)

CM13/00191 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2014

CONTRATO POSTDOCTORAL DE INVESTIGACION SARA BORRELL

Investigador Principal: ANTONIO PELLICER MARTÍNEZ

CD15/00058 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2016

TRAMIENTO COMBINADO DE VITAMINA D CON AGNRH SOBRE EL CRECIMIENTO DE LOS MIOMAS UTERINOS

Investigador Principal: ANTONIO PELLICER MARTÍNEZ

PI15/00312 . INSTITUTO DE SALUD CARLOS III . 2016

Alternativas para la Preservacion de la fertilidad en pacientes con leucemia aguda. Maduracion in vivo mediante xenotransplante.

Investigador Principal: ANTONIO PELLICER MARTÍNEZ

GRISOLIAP/2018/029 . CONSELLERIA DE EDUCACION . 2018

Searching for the pathological window of implantation and its therapeutic targets for its clinical translation for precision medicine in reproduction.

Investigador Principal: PATRICIA DÍAZ GIMENO

PI19/00537 . INSTITUTO DE SALUD CARLOS III . 2020

ESTUDIO ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO, PARA EVALUAR SEGURIDAD Y EFICACIA DE ELAGOLIX EN PARTICIPANTES CON DOLOR MODERADO O SEVERO ASOCIADO A ENDOMETRIOSIS.

Investigador Principal: VICENTE PAYÁ AMATE

M12-671

Contrato PFIS 2020. Pablo García Acero

Investigador Principal: PATRICIA DÍAZ GIMENO

FI20/00085 . INSTITUTO DE SALUD CARLOS III . 2021

Contratos Miguel Servet I 2020. Patricia Díaz Gimeno.

Investigador Principal: PATRICIA DÍAZ GIMENO

CP20/00118 . INSTITUTO DE SALUD CARLOS III . 2021

IMPACTO DE LA INFECCIÓN POR SARS-COV-2 (COVID-19) EN EL ENDOMETRIO HUMANO: EVALUACIÓN IN VITRO DE LOS EFECTOS DE HIDROXICLOROQUINA (HCQ) UTILIZANDO ORGANOIDES ENDOMETRIALES HUMANOS.

Investigador Principal: IRENE CERVELLÓ ALCARAZ

2020-268-1_CRC FERRING COVID_CERVELLO . FERRING PHARMACEUTICALS A/S . 2020

Efecto de la Vitamina D y los Disruptores Endocrinos sobre la Longitud Telomérica en Células del Cúmulo y los Resultados Reproductivos.

Investigador Principal: ANTONIO PELLICER MARTÍNEZ

PI21/00310 . INSTITUTO DE SALUD CARLOS III . 2022

Contratos Sara Borrell 2021. SEBASTIÁN LEÓN, PATRICIA

Investigador Principal: PATRICIA DÍAZ GIMENO

CD21/00132 . INSTITUTO DE SALUD CARLOS III . 2022

PREPARACION DE FOLICULOS ANTRALES, PREVIA A FECUNDACION IN VITRO TIPO ICSI, EN PACIENTES CON BAJA RESPUESTA OVARICA. ENSAYO CLINICO PROSPECTIVO ALEATORIZADO CONTROLADO.

Investigador Principal: CÉSAR DÍAZ GARCÍA

FOLLPRIM

IMPACT OF SERUM PROGESTERONE CONCENTRATION ON THE DAY OF EMBRYO TRANSFER IN MODIFIED NATURAL CYCLES AND STIMULATED CYCLES ON ONGOING PREGNANCY RATE.

Investigador Principal: MARÍA ELENA LABARTA DEMUR

IVI-PRO-2019-02

PLASMA RICO EN PLAQUETAS PROCEDENTE DE CORDÓN UMBILICAL PARA EL TRATAMIENTO DE PATOLOGÍAS ENDOMETRIALES (ENDOMETRIO FINO/ SÍNDROME DE ASHERMAN/ ATROFIA ENDOMETRIAL): UN ESTUDIO PILOTO.

Investigador Principal: MÓNICA ROMEU VILLARROYA

2001-FIVI-002-IC . 2021

Estudio de los mecanismos moleculares relacionados con la resistencia a insulina y resistencia a progesterona que influyen en la receptividad endometrial en pacientes con adenomiosis.

Investigador Principal: ANTONIO PELLICER MARTÍNEZ

FPU21/01178 . MINISTERIO DE UNIVERSIDADES . 2022

Estudio transcriptómico y secretómico de embriones euploides y aneuploides desde etapas preimplantacionales hasta etapas postimplantacionales tempranas. . AICO. Francisco Domínguez y Patricia Díaz

Investigador Principal: FRANCISCO DOMÍNGUEZ HERNÁNDEZ

CIAICO/2022/203 . CONSELLERIA DE INNOVACIÓN, UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL . 2023

ENDOAGE: A molecular clock for endometrial aging as a prognostic tool for improving assisted reproductive treatments (ARTs).

Investigador Principal: ANA MARÍA MONZÓ MIRALLES

2208-FIVI-110-PD . 2024

ENDOAGE: Un reloj molecular de envejecimiento endometrial como herramienta pronóstica para mejorar los tratamientos de reproducción asistida

Investigador Principal: PATRICIA DÍAZ GIMENO

PI23/00806 . INSTITUTO DE SALUD CARLOS III . 2024

Búsqueda de fármacos para el fallo endometrial en los tratamientos de reproducción asistida mediante farmacología de sistemas.

Investigador Principal: FRANCISCO JOSÉ SANZ LÓPEZ

CIGE/2023/117 . CONSELLERIA DE INNOVACIÓN, UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL . 2024

Cita

Compartir